These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12924275)

  • 1. [Non-small cell lung cancer: 1) Molecular-target therapy].
    Muguruma H; Yano S; Sone S
    Nihon Naika Gakkai Zasshi; 2003 Jul; 92(7):1284-90. PubMed ID: 12924275
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical responses to gefinitib after failure of treatment with cetuximab in advanced non-small-cell lung cancer.
    Raez LE; Lopes G; Lilenbaum R
    J Clin Oncol; 2005 Jun; 23(18):4244-5. PubMed ID: 15961783
    [No Abstract]   [Full Text] [Related]  

  • 3. Lung cancer: looking ahead in 2004.
    Belani CP; Ramalingam S
    Clin Lung Cancer; 2004 Jan; 5(4):200. PubMed ID: 14967070
    [No Abstract]   [Full Text] [Related]  

  • 4. [Targeted therapies for lung cancer].
    Tamura K
    Rinsho Ketsueki; 2008 Aug; 49(8):616-21. PubMed ID: 18800610
    [No Abstract]   [Full Text] [Related]  

  • 5. Avastin-Tarceva combination fails in lung cancer.
    Jones D
    Nat Biotechnol; 2009 Feb; 27(2):108-9. PubMed ID: 19204674
    [No Abstract]   [Full Text] [Related]  

  • 6. [Gefitinib in non-small cell lung cancer].
    Nakagawa K
    Nihon Rinsho; 2004 Jul; 62(7):1312-20. PubMed ID: 15283149
    [No Abstract]   [Full Text] [Related]  

  • 7. Can a single pill replace doublet chemotherapy in first-line therapy of advanced non-small cell lung cancer?
    Bunn PA
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5919-20. PubMed ID: 17062660
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeted therapy for non-small cell lung cancer.
    Jett JR; Carr LL
    Am J Respir Crit Care Med; 2013 Oct; 188(8):907-12. PubMed ID: 23721055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Erlotinib. A new option for non-small cell lung cancer].
    Polk B
    Med Monatsschr Pharm; 2006 Jan; 29(1):4-6. PubMed ID: 16463547
    [No Abstract]   [Full Text] [Related]  

  • 10. New drug to treat most common lung cancer.
    FDA Consum; 2005; 39(1):3. PubMed ID: 15818792
    [No Abstract]   [Full Text] [Related]  

  • 11. Research unveils the 'who' and 'why' of gefitinib.
    Vastag B
    J Natl Cancer Inst; 2004 Sep; 96(18):1352-4. PubMed ID: 15367564
    [No Abstract]   [Full Text] [Related]  

  • 12. Trastuzumab in the treatment of advanced non-small-cell lung cancer: is there a role?
    Kalemkerian G
    J Clin Oncol; 2005 Feb; 23(6):1325-6; author reply 1326-7. PubMed ID: 15718337
    [No Abstract]   [Full Text] [Related]  

  • 13. Gefitinib. Still no convincing results in non-small cell lung cancer.
    Prescrire Int; 2010 Jun; 19(107):113. PubMed ID: 20738034
    [No Abstract]   [Full Text] [Related]  

  • 14. [Personalized, targeted treatment of non-small cell lung cancer].
    Wolf J
    Dtsch Med Wochenschr; 2011 Mar; 136(10):480-5. PubMed ID: 21365525
    [No Abstract]   [Full Text] [Related]  

  • 15. Bevacizumab extends survival for patients with nonsquamous non-small-cell lung cancer.
    Belani CP; Ramalingam S
    Clin Lung Cancer; 2005 Mar; 6(5):267-8. PubMed ID: 15845175
    [No Abstract]   [Full Text] [Related]  

  • 16. Cetuximab: potential role as first-line treatment for advanced non-small cell lung cancer.
    Pirker R
    Clin Adv Hematol Oncol; 2008 Oct; 6(10):735-6. PubMed ID: 18997663
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of gefitinib as monotherapy for Chinese patients with advanced non-small cell lung cancer.
    Wang MZ; Li LY; Wang SL; Zhang XT; Zhong W; Zhang L
    Chin Med J (Engl); 2006 Jan; 119(1):63-8. PubMed ID: 16454984
    [No Abstract]   [Full Text] [Related]  

  • 18. Gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC).
    Bearz A; Fratino L; Spazzapan S; Berretta M; Giacalone A; Simonelli C; Tirelli U
    Lung Cancer; 2007 Jan; 55(1):125-7. PubMed ID: 17064811
    [No Abstract]   [Full Text] [Related]  

  • 19. The impact of epidermal-growth-factor-receptor mutations in response to lung-cancer therapy.
    Dowell JE; Minna JD
    Nat Clin Pract Oncol; 2004 Nov; 1(1):2-3. PubMed ID: 16264773
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeted therapies in non-small-cell lung cancer: a paradigm in evolution.
    Sangha R; Lara PN; Mack P; Gandara DR
    Clin Lung Cancer; 2008; 9 Suppl 3():S90-1. PubMed ID: 19419929
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.